Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systems modeling accurately predicts responses to genotoxic agents and their synergism with BCL-2 inhibitors in triple negative breast cancer cells
Federico Lucantoni, Andreas U. Lindner, Norma O’Donovan, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Targeting apoptosis in cancer therapy
Benedito A. Carneiro, Wafik S. El‐Deiry
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 395-417
Open Access | Times Cited: 1913
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer
Sara Socorro Faria, Susan Costantini, Vladmir Cláudio Cordeiro de Lima, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 123
Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 94
Triple‑negative breast cancer: A run‑through of features, classification and current therapies (Review)
Meghana Manjunath, Bibha Choudhary
Oncology Letters (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 74
It's time to die: BH3 mimetics in solid tumors
Sarah Kehr, Meike Vogler
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2021) Vol. 1868, Iss. 5, pp. 118987-118987
Open Access | Times Cited: 60
Adapted to Survive: Targeting Cancer Cells with BH3 Mimetics
Joan Montero, Rizwan Haq
Cancer Discovery (2022) Vol. 12, Iss. 5, pp. 1217-1232
Open Access | Times Cited: 46
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy
Caterina Vianello, Veronica Cocetta, Daniela Catanzaro, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 4
Open Access | Times Cited: 39
Current Advances and Future Strategies for BCL-2 Inhibitors: Potent Weapons against Cancers
Jiaxuan Xu, Xiaoqing Dong, David C.S. Huang, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4957-4957
Open Access | Times Cited: 23
Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression
Aml Ghanem, Mohamed A. Ali, Mohamed A. Elkady, et al.
Pathology - Research and Practice (2023) Vol. 250, pp. 154807-154807
Closed Access | Times Cited: 19
Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer
Bruno de Paula, Rosalind Kieran, Samantha Shui Yuan Koh, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 5, pp. 583-598
Open Access | Times Cited: 16
BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose
Federico Lucantoni, Heiko Düßmann, Irene Llorente‐Folch, et al.
Oncotarget (2018) Vol. 9, Iss. 40, pp. 26046-26063
Open Access | Times Cited: 43
Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
Daniel Westaby, Juan M. Jiménez‐Vacas, Ana Padilha, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 51-51
Open Access | Times Cited: 27
Targeting anti-apoptotic mechanisms in tumour cells: Strategies for enhancing Cancer therapy
Benu Chaudhary, Preeti Arya, Vikas Sharma, et al.
Bioorganic Chemistry (2025), pp. 108388-108388
Closed Access
Potential of Orlistat to induce apoptotic and antiangiogenic effects as well as inhibition of fatty acid synthesis in breast cancer cells
Jovana Jovankić, Danijela Nikodijević, Milena Milutinović, et al.
European Journal of Pharmacology (2022) Vol. 939, pp. 175456-175456
Closed Access | Times Cited: 17
Landscape analysis of adjacent gene rearrangements reveals BCL2L14–ETV6 gene fusions in more aggressive triple-negative breast cancer
Sang Hoon Lee, Yiheng Hu, Suet Kee Loo, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 18, pp. 9912-9921
Open Access | Times Cited: 27
BCL(X)L and BCL2 increase the metabolic fitness of breast cancer cells: a single-cell imaging study
Federico Lucantoni, Manuela Salvucci, Heiko Düßmann, et al.
Cell Death and Differentiation (2020) Vol. 28, Iss. 5, pp. 1512-1531
Open Access | Times Cited: 26
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemia
Eileen Hu, Priscilla Do, Swagata Goswami, et al.
Blood Advances (2021) Vol. 5, Iss. 16, pp. 3152-3162
Open Access | Times Cited: 22
An atlas of inter- and intra-tumor heterogeneity of apoptosis competency in colorectal cancer tissue at single-cell resolution
Andreas U. Lindner, Manuela Salvucci, Elizabeth McDonough, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 4, pp. 806-817
Open Access | Times Cited: 22
From solid state to in vitro anticancer activity of copper(ii) compounds with electronically-modulated NNO Schiff base ligands
Luca Rigamonti, Francesco Reginato, Érika Ferrari, et al.
Dalton Transactions (2020) Vol. 49, Iss. 41, pp. 14626-14639
Closed Access | Times Cited: 23
BAX and SMAC regulate bistable properties of the apoptotic caspase system
Stephanie McKenna, Lucía García-Gutiérrez, David Matallanas, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
The identification of BCL-XL and MCL-1 as key anti-apoptotic proteins in medulloblastoma that mediate distinct roles in chemotherapy resistance
Marie-Claire Fitzgerald, Philip J. O’Halloran, Sean A Kerrane, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 6
Targeted and Intrinsic Activity of HA-Functionalized PEI-Nanoceria as a Nano Reactor in Potential Triple-Negative Breast Cancer Treatment
Nipun Babu Varukattu, Wan‐Wan Lin, Raju Vivek, et al.
ACS Applied Bio Materials (2019) Vol. 3, Iss. 1, pp. 186-196
Closed Access | Times Cited: 17
Paip1 Indicated Poor Prognosis in Cervical Cancer and Promoted Cervical Carcinogenesis
Nan Li, Junjie Piao, Xinyue Wang, et al.
Cancer Research and Treatment (2019) Vol. 51, Iss. 4, pp. 1653-1665
Open Access | Times Cited: 16
Comparative DNA-/BSA-binding, DNA cleavage, and cytotoxic properties of copper(II) amino/salicyl-phenolate Schiff bases (phen) complexes that induce generation of phenoxyl radicals
Anjaneyulu Mamindla, Manikandan Varadhan, Radhakrishnan Kartikeyan, et al.
Polyhedron (2023) Vol. 243, pp. 116534-116534
Closed Access | Times Cited: 5
Counting on Death – Quantitative aspects of Bcl‐2 family regulation
Annika Hantusch, Markus Rehm, Thomas Brunner
FEBS Journal (2018) Vol. 285, Iss. 22, pp. 4124-4138
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top